Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration Nigel H. GreigShigeru GenkaStanley I. Rapoport Original Articles Pages: 311 - 319
Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain Nigel H. GreigEileen M. DalyStanley I. Rapoport Original Articles Pages: 320 - 325
Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats Romano DanesiNunzia BernardiniMario Del Tacca Original Articles Pages: 326 - 332
Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate Elena MontiLuisa ParacchiniRosanna Supino Original Articles Pages: 333 - 336
In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea J. L. FischelP. FormentoG. Milano Original Articles Pages: 337 - 341
Effect of whole-body hyperthermia on hepatic cytochrome P450 A. J. NevilleG. Singh Original Articles Pages: 342 - 344
Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies Gilberto SchwartsmannPierre DodionHerbert M. Pinedo Original Articles Pages: 345 - 351
Relationship between the pharmacokinetics and toxicity of mitozolomide D. J. KerrJ. A. SlackS. B. Kaye Original Articles Pages: 352 - 354
Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer Francesco Di ReSilvia BohmFranco Zunino Original Articles Pages: 355 - 360
Clinical pharmacodynamics of continuous-infusion etoposide Antonius A. MillerClinton F. StewartElizabeth A. Tolley Original Articles Pages: 361 - 366
Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer James F. BishopRichard KeffordAlan Zimet Original Articles Pages: 367 - 370
False-positive ketone tests: a bedside measure of urinary mesna Marshall P. GorenCharles B. Pratt Original Articles Pages: 371 - 372
High-dose cisplatin in disseminated melanoma: a comparison of two schedules Joanne E. MortimerSusan SchulmanGary Goodman Original Articles Pages: 373 - 376
The 5-HT3 antagonist, BRL 43694, does not compromise the efficacy of cisplatin in tumour-bearing mice Phyllis M. GoddardMervyn JonesKenneth R. Harrap Short Communication Pages: 377 - 379
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer David C. CurrieDavid W. MilesRobert L. Souhami Short Communication Pages: 380 - 381
Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study L. Thomas VlasveldJos H. BeynenSjoerd Rodenhuis Short Communication Pages: 382 - 383
Methotrexate sensitivity in Down's syndrome: a hypothesis P. M. UelandH. RefsumB. Christensen Letter to the Editors Pages: 384 - 386
The case of Vepesid overdosage in a patient with Hodgkin's disease Marek PawlickiBeata Zuchowska-VogelgesangElzbieta Sliz Letter to the Editors Pages: 387 - 387
